How the FDA Turned a $10 Treatment into a $1500
Money-Maker for a Sanctioned Drug Company
|
(The Best Years in Life) What's a poor faltering drug company to do when it has been busted for misdeeds, its shareholders are up in arms and its former CEO has been fined, sent to jail and banned from the industry? In the case of KV Pharmaceutical, the answer was to get the FDA to give the company exclusive rights to a common generic drug for expectant mothers and raise the price from $10 per treatment to $1500 - a decision which has outraged doctors, US senators, and even the March of Dimes. Read More: http://www.tbyil.com/FDA_KV_Pharma.htm See also: "Scandal at the FDA: board members with drug maker ties voted to approve drug that's killing women" http://www.tbyil.com/FDA_Scandal_Drospirenone.htm http://www.rumormillnews.com/cgi-bin/forum.cgi?read=274950 |
No comments:
Post a Comment